Aquestive Therapeutics, Inc. (AQST)
4.795
+0.14
(+2.90%)
USD |
NASDAQ |
Aug 24, 16:00
4.71
-0.08
(-1.77%)
After-Hours: 20:00
Aquestive Therapeutics Total Assets (Quarterly) : 132.10M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 132.10M |
| March 31, 2026 | 141.12M |
| December 31, 2025 | 162.17M |
| September 30, 2025 | 163.56M |
| June 30, 2025 | 93.70M |
| March 31, 2025 | 102.23M |
| December 31, 2024 | 101.42M |
| September 30, 2024 | 109.96M |
| June 30, 2024 | 117.60M |
| March 31, 2024 | 129.52M |
| December 31, 2023 | 57.42M |
| September 30, 2023 | 59.45M |
| June 30, 2023 | 56.99M |
| March 31, 2023 | 61.28M |
| December 31, 2022 | 57.07M |
| September 30, 2022 | 51.84M |
| June 30, 2022 | 56.31M |
| March 31, 2022 | 56.53M |
| Date | Value |
|---|---|
| December 31, 2021 | 61.99M |
| September 30, 2021 | 65.29M |
| June 30, 2021 | 66.88M |
| March 31, 2021 | 61.92M |
| December 31, 2020 | 62.88M |
| September 30, 2020 | 50.42M |
| June 30, 2020 | 63.55M |
| March 31, 2020 | 64.49M |
| December 31, 2019 | 78.48M |
| September 30, 2019 | 48.82M |
| June 30, 2019 | 50.41M |
| March 31, 2019 | 67.98M |
| December 31, 2018 | 86.85M |
| September 30, 2018 | 90.01M |
| June 30, 2018 | 39.84M |
| March 31, 2018 | 46.08M |
| December 31, 2017 | 43.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 236.60M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 188.69M |
| Shareholders Equity (Quarterly) | -56.59M |
| Debt to Equity Ratio | -2.635 |
| Current Ratio | 7.191 |
| Net Debt Paydown Yield | -0.94% |